Indeed, in breast cancer patients with variants such as in BRCA1, BRCA2, and ATM, it is recommended that the contralateral breast dose in mammography and radiotherapy be minimized in order to prevent secondary carcinogenesis33. This evidence concerns the gene BRCA1 and breast cancer.